Cargando…
Oral anticoagulation therapy : cases and clinical correlation /
Given the amount and complexity of information surrounding the the target specific oral anticoagulants a lengthy didactic educational format has the potential to be overwhelming to the reader and difficult to translate and apply to direct patient care. The proposed book will educate clinicians utili...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Cham, Switzerland :
Springer,
[2017]
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | EBOOKCENTRAL_ocn988773406 | ||
| 003 | OCoLC | ||
| 005 | 20240329122006.0 | ||
| 006 | m o d | ||
| 007 | cr cnu|||unuuu | ||
| 008 | 170602s2017 sz ob 001 0 eng d | ||
| 040 | |a N$T |b eng |e rda |e pn |c N$T |d N$T |d EBLCP |d GW5XE |d YDX |d AZU |d UPM |d OCLCF |d COO |d VT2 |d OCLCQ |d UAB |d IOG |d MERER |d OCLCQ |d U3W |d CAUOI |d OCLCQ |d KSU |d AU@ |d ESU |d OCLCQ |d LVT |d WYU |d OCLCQ |d AUD |d CASUM |d OCLCO |d UKMGB |d OCLCO |d UKAHL |d OCLCQ |d ERF |d OCLCQ |d OCLCA |d OCLCQ |d OCLCA |d OCLCQ |d SRU |d COM |d OCLCO |d OCLCQ |d OCLCO |d OCLCL |d OCLCQ | ||
| 015 | |a GBB954259 |2 bnb | ||
| 016 | 7 | |a 019305077 |2 Uk | |
| 019 | |a 989037816 |a 992539316 |a 992825722 |a 999514104 |a 1005757990 |a 1011852584 |a 1048120890 |a 1058645338 |a 1066439316 |a 1066691626 |a 1086492045 |a 1112538599 | ||
| 020 | |a 9783319546438 |q (electronic bk.) | ||
| 020 | |a 3319546430 |q (electronic bk.) | ||
| 020 | |a 3319546414 | ||
| 020 | |a 9783319546414 | ||
| 020 | |z 9783319546414 | ||
| 024 | 7 | |a 10.1007/978-3-319-54643-8 |2 doi | |
| 029 | 1 | |a AU@ |b 000060699683 | |
| 029 | 1 | |a GBVCP |b 89041369X | |
| 029 | 1 | |a UKMGB |b 019305077 | |
| 035 | |a (OCoLC)988773406 |z (OCoLC)989037816 |z (OCoLC)992539316 |z (OCoLC)992825722 |z (OCoLC)999514104 |z (OCoLC)1005757990 |z (OCoLC)1011852584 |z (OCoLC)1048120890 |z (OCoLC)1058645338 |z (OCoLC)1066439316 |z (OCoLC)1066691626 |z (OCoLC)1086492045 |z (OCoLC)1112538599 | ||
| 037 | |a com.springer.onix.9783319546438 |b Springer Nature | ||
| 050 | 4 | |a RM340 | |
| 060 | 4 | |a 2017 H-635 | |
| 060 | 4 | |a QV 193 | |
| 072 | 7 | |a MED |x 071000 |2 bisacsh | |
| 072 | 7 | |a MJD |2 bicssc | |
| 082 | 0 | 4 | |a 615.7/18 |2 23 |
| 049 | |a UAMI | ||
| 245 | 0 | 0 | |a Oral anticoagulation therapy : |b cases and clinical correlation / |c Kathryn Kiser, editor. |
| 264 | 1 | |a Cham, Switzerland : |b Springer, |c [2017] | |
| 264 | 4 | |c ©2017 | |
| 300 | |a 1 online resource | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a text file |b PDF |2 rda | ||
| 588 | 0 | |a Online resource; title from PDF title page (EBSCO, viewed June 8, 2017). | |
| 504 | |a Includes bibliographical references and index. | ||
| 520 | |a Given the amount and complexity of information surrounding the the target specific oral anticoagulants a lengthy didactic educational format has the potential to be overwhelming to the reader and difficult to translate and apply to direct patient care. The proposed book will educate clinicians utilizing a series of clinical cases to simultaneously develop the readers' knowledge base, problem-solving skills, and practically apply their new knowledge to a variety of clinical situations. These will be short focused case presentations that provide critical information and pose questions to the reader at key points in the decision making process. The cases will be relevant to what clinicians will encounter not only on a daily basis, but also reflective of scenarios that clinicians will not encounter regularly, but that they will have to act upon (e.g. a bleeding patient, patient scheduled for elective or emergent procedure, patient with changing renal function, patient on drugs that have a plausible yet unstudied drug interaction with a target specific oral anticoagulant etc). Included in the case studies will be evidence-based discussions (with appropriate references) that provide immediate feedback on the different treatment alternatives that were offered. The case studies will be designed to instruct the reader how to select and effectively utilize the most appropriate agent for a given clinical scenario. They will focus on key features of the target specific oral anticoagulants, what they have in common, how they are unique from each other, as well as illustrating the clinical decision process one should take when selecting an agent or managing a patient already receiving one of the target specific oral agents. | ||
| 505 | 0 | |a Part I: Introduction; Chapter 1: Introduction; Part II: Atrial Fibrillation; Chapter 2: CHA2DS2-VASc and HAS-BLED Risk Stratification Tools; Case Introduction; Case Discussion; Risk of Stroke; Risk of Bleeding; How Does a Clinician Choose Among the Various Agents for Stroke Prevention?; Key Points; Self-Assessment Questions; References; Chapter 3: Male with Priority of Ischemic Stroke Reduction; Discussion; Key Points; Self-Assessment Questions; References; Chapter 4: Choosing an Anticoagulant in an Elderly Patient; Case Introduction; Case Discussion; Key Points. | |
| 505 | 8 | |a Self-Assessment QuestionsReferences; Chapter 5: Patient with Prior History of GI Hemorrhage; Case Introduction; Case Discussion; Key Points; Self-Assessment Questions; References; Chapter 6: Patients with a History of Intracranial Hemorrhage; Case Introduction; Key Points; Self-Assessment Questions; References; Chapter 7: Concerns with Anticoagulant Adherence; Key Points; Self-Assessment Questions; References; Chapter 8: Oral Anticoagulants in Stable Moderate Chronic Kidney Disease; Case Introduction; Case Discussion; Background. | |
| 505 | 8 | |a What Factors Should be Considered When Selecting an Oral Anticoagulant for Patients with Stable Moderate Renal Function? The Outcome; Key Points; Self-Assessment Questions; References; Chapter 9: Oral Anticoagulants in Severe Renal Dysfunction; Case Discussion; What Is this Patient's Risk of Stroke and Bleeding?; What Is the Evidence for Use of Direct Oral Anticoagulants (DOACs) in Severe CKD?; What Are Considerations When Using Warfarin in CKD?; What Is the Best Anticoagulation Plan for this Patient?; Key Points; Self-Assessment Questions; References. | |
| 505 | 8 | |a Chapter 10: Oral Anticoagulants in Patients with Variable Renal Function Case Introduction; Case Discussion; Background; Considerations for DOAC Management in Variable Renal Function; Upon Admission; Case Continuation; Prior to Discharge; Case Continuation; During Hospitalization Follow-up; The Outcome; Key Points; Self-Assessment Questions; References; Chapter 11: Patient with Concomitant Stable Coronary Artery Disease; Case Discussion; Key Points; Self-Assessment Questions; References; Chapter 12: Patient with Concomitant Acute Venous Thromboembolism; Case Introduction. | |
| 505 | 8 | |a Case Discussion Key Points; Self-Assessment Questions; References; Chapter 13: Patient with Concomitant Mitral Valve Stenosis; Case Introduction; Case Discussion; Key Points; Self-Assessment Questions; References; Chapter 14: Patient with Concomitant Aortic Valve Stenosis; Case Introduction; Case Discussion; Key Points; Self Assessment Questions; References; Part III: Warfarin Management; Chapter 15: Best Practice for Switching Stable Warfarin Patients; Case Introduction; Case Discussion; FDA-Approved Indications for Use; Comparison of DOACs with Warfarin. | |
| 590 | |a ProQuest Ebook Central |b Ebook Central Academic Complete | ||
| 650 | 0 | |a Anticoagulants (Medicine) |v Case studies. | |
| 650 | 0 | |a Oral medication |v Case studies. | |
| 650 | 0 | |a Oral medication. | |
| 650 | 1 | 2 | |a Anticoagulants |x therapeutic use |
| 650 | 2 | 2 | |a Administration, Oral |
| 650 | 2 | 2 | |a Hemorrhage |x drug therapy |
| 650 | 2 | 2 | |a Vascular Diseases |x drug therapy |
| 650 | 2 | 2 | |a Warfarin |x therapeutic use |
| 650 | 6 | |a Anticoagulants |v Études de cas. | |
| 650 | 6 | |a Médicaments |x Administration par voie orale |v Études de cas. | |
| 650 | 6 | |a Médicaments |x Administration par voie orale. | |
| 650 | 7 | |a MEDICAL |x Pharmacology. |2 bisacsh | |
| 650 | 7 | |a Anticoagulants (Medicine) |2 fast | |
| 650 | 7 | |a Oral medication |2 fast | |
| 655 | 2 | |a Case Reports | |
| 655 | 4 | |a Case Reports. | |
| 655 | 4 | |a Fulltext. | |
| 655 | 4 | |a Internet Resources. | |
| 655 | 7 | |a Case studies |2 fast | |
| 655 | 7 | |a Case studies. |2 lcgft | |
| 655 | 7 | |a Études de cas. |2 rvmgf | |
| 700 | 1 | |a Kiser, Kathryn, |e editor. | |
| 758 | |i has work: |a Oral anticoagulation therapy (Text) |1 https://id.oclc.org/worldcat/entity/E39PCYQ8FxxKwHQwcqwCcbc3wC |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Printed edition: |z 9783319546414 |
| 856 | 4 | 0 | |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=4869396 |z Texto completo |
| 938 | |a Askews and Holts Library Services |b ASKH |n AH33065865 | ||
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL4869396 | ||
| 938 | |a EBSCOhost |b EBSC |n 1528912 | ||
| 938 | |a YBP Library Services |b YANK |n 14537300 | ||
| 994 | |a 92 |b IZTAP | ||